On September 15, 2026, Zhiyong Hu's long position in GENSCRIPT BIO (01548) was passively diluted due to the company's placement of 77,126,000 new shares under a general mandate. This event is not a direct on-market dealing by the investor.
Prior to the placement, Zhiyong Hu held 801.15 million shares, representing 36.36% of the company's issued shares. Following the placement, the holding count was unchanged at 801.15 million shares, but the long position ratio fell to 35.13%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments